Atlas Trials

Long-term Safety and Efficacy Study of MND-2119 in Patients With Hypertriglyceridemia

Clinical trial NCT04221217 · COMPLETED

Trial details

NCT number
NCT04221217
Sponsor
Mochida Pharmaceutical Company, Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypertriglyceridemia
Start date
2020-02-14
Primary completion
2021-07-14
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.